IBDEI0HC ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23327,1,5,0)
 ;;=5^Pressure Ulcer,Stage IV
 ;;^UTILITY(U,$J,358.3,23327,2)
 ;;=^336652
 ;;^UTILITY(U,$J,358.3,23328,0)
 ;;=707.25^^152^1371^46
 ;;^UTILITY(U,$J,358.3,23328,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23328,1,4,0)
 ;;=4^707.25
 ;;^UTILITY(U,$J,358.3,23328,1,5,0)
 ;;=5^Pressure Ulcer,Unstagebl
 ;;^UTILITY(U,$J,358.3,23328,2)
 ;;=^336653
 ;;^UTILITY(U,$J,358.3,23329,0)
 ;;=707.20^^152^1371^45
 ;;^UTILITY(U,$J,358.3,23329,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23329,1,4,0)
 ;;=4^707.20
 ;;^UTILITY(U,$J,358.3,23329,1,5,0)
 ;;=5^Pressure Ulcer,Stage NOS
 ;;^UTILITY(U,$J,358.3,23329,2)
 ;;=^336761
 ;;^UTILITY(U,$J,358.3,23330,0)
 ;;=V18.0^^152^1372^15
 ;;^UTILITY(U,$J,358.3,23330,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23330,1,4,0)
 ;;=4^V18.0
 ;;^UTILITY(U,$J,358.3,23330,1,5,0)
 ;;=5^Family h/o Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,23330,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,23331,0)
 ;;=V16.0^^152^1372^8
 ;;^UTILITY(U,$J,358.3,23331,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23331,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,23331,1,5,0)
 ;;=5^Family h/o Cancer of GI Tract
 ;;^UTILITY(U,$J,358.3,23331,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,23332,0)
 ;;=V16.1^^152^1372^9
 ;;^UTILITY(U,$J,358.3,23332,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23332,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,23332,1,5,0)
 ;;=5^Family h/o Cancer of Lung
 ;;^UTILITY(U,$J,358.3,23332,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,23333,0)
 ;;=V19.6^^152^1372^2
 ;;^UTILITY(U,$J,358.3,23333,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23333,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,23333,1,5,0)
 ;;=5^Family h/o Allergic Disorder
 ;;^UTILITY(U,$J,358.3,23333,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,23334,0)
 ;;=V18.2^^152^1372^3
 ;;^UTILITY(U,$J,358.3,23334,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23334,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,23334,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,23334,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,23335,0)
 ;;=V17.5^^152^1372^5
 ;;^UTILITY(U,$J,358.3,23335,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23335,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,23335,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,23335,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,23336,0)
 ;;=V17.7^^152^1372^4
 ;;^UTILITY(U,$J,358.3,23336,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23336,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,23336,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,23336,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,23337,0)
 ;;=V19.0^^152^1372^6
 ;;^UTILITY(U,$J,358.3,23337,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23337,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,23337,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,23337,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,23338,0)
 ;;=V16.3^^152^1372^7
 ;;^UTILITY(U,$J,358.3,23338,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23338,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,23338,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,23338,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,23339,0)
 ;;=V16.41^^152^1372^10
 ;;^UTILITY(U,$J,358.3,23339,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23339,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,23339,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,23339,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,23340,0)
 ;;=V16.42^^152^1372^11
 ;;^UTILITY(U,$J,358.3,23340,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23340,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,23340,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,23340,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,23341,0)
 ;;=V16.43^^152^1372^12
 ;;^UTILITY(U,$J,358.3,23341,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23341,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,23341,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,23341,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,23342,0)
 ;;=V19.5^^152^1372^13
 ;;^UTILITY(U,$J,358.3,23342,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23342,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,23342,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,23342,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,23343,0)
 ;;=V19.2^^152^1372^14
 ;;^UTILITY(U,$J,358.3,23343,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23343,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,23343,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,23343,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,23344,0)
 ;;=V17.3^^152^1372^16
 ;;^UTILITY(U,$J,358.3,23344,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23344,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,23344,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,23344,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,23345,0)
 ;;=V16.6^^152^1372^17
 ;;^UTILITY(U,$J,358.3,23345,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23345,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,23345,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,23345,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,23346,0)
 ;;=V18.61^^152^1372^19
 ;;^UTILITY(U,$J,358.3,23346,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23346,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,23346,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,23346,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,23347,0)
 ;;=V17.0^^152^1372^20
 ;;^UTILITY(U,$J,358.3,23347,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23347,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,23347,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,23347,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,23348,0)
 ;;=V19.4^^152^1372^21
 ;;^UTILITY(U,$J,358.3,23348,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23348,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,23348,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,23348,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,23349,0)
 ;;=V17.1^^152^1372^22
 ;;^UTILITY(U,$J,358.3,23349,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23349,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,23349,1,5,0)
 ;;=5^Family h/o Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,23349,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,23350,0)
 ;;=V16.8^^152^1372^18
 ;;^UTILITY(U,$J,358.3,23350,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23350,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,23350,1,5,0)
 ;;=5^Family h/o Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,23350,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,23351,0)
 ;;=V11.1^^152^1372^41
 ;;^UTILITY(U,$J,358.3,23351,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23351,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,23351,1,5,0)
 ;;=5^Personal h/o Affective Disorder
 ;;^UTILITY(U,$J,358.3,23351,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,23352,0)
 ;;=V15.89^^152^1372^49
 ;;^UTILITY(U,$J,358.3,23352,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23352,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,23352,1,5,0)
 ;;=5^Personal h/o Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,23352,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,23353,0)
 ;;=V11.3^^152^1372^42
 ;;^UTILITY(U,$J,358.3,23353,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23353,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,23353,1,5,0)
 ;;=5^Personal h/o Alcoholism
 ;;^UTILITY(U,$J,358.3,23353,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,23354,0)
 ;;=V15.07^^152^1372^43
 ;;^UTILITY(U,$J,358.3,23354,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23354,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,23354,1,5,0)
 ;;=5^Personal h/o Allerlgy to Latex
 ;;^UTILITY(U,$J,358.3,23354,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,23355,0)
 ;;=V13.4^^152^1372^44
 ;;^UTILITY(U,$J,358.3,23355,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23355,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,23355,1,5,0)
 ;;=5^Personal h/o Arthritis
 ;;^UTILITY(U,$J,358.3,23355,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,23356,0)
 ;;=V12.72^^152^1372^45
 ;;^UTILITY(U,$J,358.3,23356,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23356,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,23356,1,5,0)
 ;;=5^Personal h/o Colon Polyps
 ;;^UTILITY(U,$J,358.3,23356,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,23357,0)
 ;;=V12.59^^152^1372^46
 ;;^UTILITY(U,$J,358.3,23357,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23357,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,23357,1,5,0)
 ;;=5^Personal h/o Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,23357,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,23358,0)
 ;;=V45.81^^152^1372^47
 ;;^UTILITY(U,$J,358.3,23358,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23358,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,23358,1,5,0)
 ;;=5^Personal h/o Coronary Bypass
 ;;^UTILITY(U,$J,358.3,23358,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,23359,0)
 ;;=V15.84^^152^1372^48
 ;;^UTILITY(U,$J,358.3,23359,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23359,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,23359,1,5,0)
 ;;=5^Personal h/o Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,23359,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,23360,0)
 ;;=V15.85^^152^1372^53
 ;;^UTILITY(U,$J,358.3,23360,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23360,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,23360,1,5,0)
 ;;=5^Personal h/o Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,23360,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,23361,0)
 ;;=V10.72^^152^1372^51
 ;;^UTILITY(U,$J,358.3,23361,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23361,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,23361,1,5,0)
 ;;=5^Personal h/o Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,23361,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,23362,0)
 ;;=V15.3^^152^1372^52
 ;;^UTILITY(U,$J,358.3,23362,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23362,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,23362,1,5,0)
 ;;=5^Personal h/o Irradiation
 ;;^UTILITY(U,$J,358.3,23362,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,23363,0)
 ;;=V10.61^^152^1372^26
 ;;^UTILITY(U,$J,358.3,23363,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23363,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,23363,1,5,0)
 ;;=5^Hx of Lymphoid Leukemia
